-
-
-
-
-
-
-
Tempus AI Inc (TEM) PT Lowered to $70 at BTIG
-
-
-
-
-
-
-
Canaccord Reiterates Buy Rating on Tempus AI Inc (TEM)
-
-
-
-
-
-
-
TD Cowen notes short interest shifts in life science tools stocks
-
-
-
-
-
-
-
Tempus AI to present 37 research abstracts at 2026 ASCO meeting
-
-
-
-
-
-
-
Tempus and Predicta partner on blood cancer genome testing assay
-
-
-
-
-
-
-
Tempus AI Inc (TEM) PT Lowered to $60 at Stifel, Firm Highlights 'Solid' Outlook
-
-
-
-
-
-
-
Tempus launches AI-powered biomarker prediction tool Paige Predict
-
459,733 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

